2009年4月18日星期六
Pleural mesothelioma
Pleural mesothelioma is pleural primary tumor, localized (mostly benign) and diffuse (all malignant) Points. One of diffuse malignant mesothelioma of the chest tumor one of the worst prognosis. The majority of patients in the 40-70 age Among men more than women. The first symptoms chest pain, cough and shortness of breath is the most common. Also in fever, sweating or joint pain symptoms mainly v. Persons. About half of these patients with massive pleural effusion serious shortness of breath. Chest pain without substantial pleural effusion, often more drama Ranariddh, weight loss common. Ordinary X-ray found pleural effusion, pulmonary tumor tissue was wrapped, late There are cases of pericardial effusion caused the heart to expand and Ying Ying and soft tissue damage and ribs. The suspected malignant pleural mesothelioma patients, CT is most useful. Cytological examination of pleural fluid also helped consultation Broken. Routine laboratory tests, some patients can increase platelet serum carcinoembryonic antigen (CEA) increased Etc.. The checks can clear diagnosis can be done thoracoscopy pleural biopsy. Most patients can generally This was the diagnosis. The treatment of malignant pleural mesothelioma is still no effective cure method. Treatment methods, a palliative In treatment, surgery, chemotherapy and radiation therapy, the tumor is generally believed that the relative limitations of the Phase I People do advocate radical resection of the lung pleura. For II, III, IV stage patients, radical surgery has no significance The only implementation of palliative surgery. In fact, the majority of patients to disease diagnosis, is in Phase II to On. The rapid growth in patients with pleural effusion often lead to serious breathing difficulties, palliative surgery for raising these nights The quality of life of patients is of great significance. Previous intrathoracic dissipated injection of chemotherapy drugs to pleural effusion or Locking adhesion method often effective. Peritoneal Mesothelioma Peritoneal mesothelioma is the primary peritoneal mesothelial cells in the tumor. A clinical performance characteristics of the common symptoms And signs are: abdominal pain, ascites, abdominal distention and abdominal mass,. Peritoneal mesothelioma about all mesothelioma cases 20% can occur in 2-92 years, with an average age of 54 years, of which about 63% of cases in 45 -- Between the age of 64, children are rarely sick. Clinical manifestations 1. Abdominal pain, bloating, ascites, abdominal mass; 2. Anorexia, nausea, vomiting, diarrhea, constipation; 3. Weak, Fever, weight loss, anemia; 4. Hypoglycemia, diffuse abdominal ossification; 5. As with other parts of peritoneal mesothelioma Mesothelioma, transferring organs and other complications corresponding performance. Diagnosis 1. Abdominal pain, bloating, ascites, abdominal mass in patients, especially the history of asbestos exposure; 2. Imaging examination of peritoneal A thin sheet signs and ascites tumor; 3. Ascites cytology screening; 4. Peritoneal biopsy, laparoscopy and laparotomy Exploration and admission to the Organization for pathological examination confirmed. Peritoneal mesothelioma originated in the epithelium and peritoneal mesothelial organizations, pathogenic material for the asbestos dust, some viruses can be Mesothelioma is caused reasons. Peritoneal mesothelioma pathology can be divided into: adenomatoid tumors, cystic mesothelioma and malignant Three of the skin. Peritoneal mesothelioma is not specific clinical performance, the positive rate is not high, specificity is not strong, The clinical diagnosis is difficult. With laparoscopy, ultrasound and CT-guided biopsy in technology and Pathology, immunohistochemistry and electron microscopy diagnosis level increases, more and more cases had been prescribed or preoperative Indeed the pathological diagnosis. Peritoneal mesothelioma mainly with tuberculous peritonitis, intra-abdominal metastases, in the abdominal other primary Membrane omentum of the tumor differentiation.
订阅:
博文评论 (Atom)
没有评论:
发表评论